Research
OCRA invests more funds into ovarian cancer research than any other public charity.
Read more about Research Read about groundbreaking OCRA-funded research
OCRA's Mission & Impact
Mission & Impact
Our Mission Statement: Ovarian Cancer Research Alliance is dedicated to curing ovarian cancer while improving treatments by advancing innovative science, promoting preventive measures, and advocating for, educating and supporting anyone affected by gynecologic cancers to ensure the best possible care and outcomes.
Results and Milestones
Numbers tell the story of our impact
- Research and Education Funding
- OCRA’s advocacy efforts have helped secure $3.8 billion in federal research and education funding
- $3.8B
- Invested in Science Innovation
- $137M raised and invested in scientific breakthroughs
- $137M
- Individuals Helped Each Year
- Our programs support more than 95,000 individuals annually
- 95K
For each dollar we spend, 81 cents goes to funding critical research and innovative programs
Advancing Research and Fueling Hope
OCRA has both a laser focus and a panoramic view when it comes to the fight against gynecologic cancers.
Advocacy
OCRA has built a team of passionate, dedicated advocates.
Read more about Advocacy Discover our advocacy impact and get involved
Patient Support
In times of adversity, support becomes a beacon of hope.
Read more about Patient Support Learn about our unique programs
OCRA's History of Impact and Innovation
Ovarian Cancer Research Alliance (OCRA) is the oldest and largest ovarian and gynecologic cancer charity in the world. Since its founding in 1994, OCRA has grown into the leading non-government funder of ovarian and related gynecologic cancer research, investing over $137 million in groundbreaking studies. Through innovative education and advocacy efforts, compassionate support programs, and cross-industry collaboration, OCRA is driving progress and pushing the boundaries of what’s possible to improve outcomes for patients and advance research in its quest for a cure.
Related Topics
OCRA Invests More than $10.8 Million Toward Research, Part of $14.5 Million Commitment in 2025
In 2025, Ovarian Cancer Research Alliance (OCRA) invested more than $10.8 million toward scientific research—part of our $14.5 million commitment to strengthen the community through research, patient support, education and advocacy. This year’s investment represents OCRA’s broadest scope to date, encompassing not only our renowned grant programs but also global collaborations leveraging artificial intelligence (AI) … Continued
The Overview: October 2025
KVIA-TV ABC-7 News El Paso recently featured OCRA-funded researcher Daniel Heller, PhD, and his team at Memorial Sloan Kettering Cancer Center, whose innovative work is bringing new hope for detecting ovarian cancer at its earliest stages through a simple blood test. Dr. Heller’s research lab is developing a liquid biopsy that uses nanosensors and artificial intelligence (AI) to measure multiple proteins … Continued
OCRA Sponsors NCCN 2025 Guidelines for Cervical, Ovarian, and Uterine Cancer Patients
This article was updated in October 2025 to reflect NCCN’s release of the 2025 Guidelines for Uterine Cancer Patients. OCRA is a proud sponsor of the 2025 Patient Guidelines for Cervical, Ovarian, and Uterine Cancer. We believe ensuring access to clear, understandable information is critical. NCCN provides wonderful guides for anyone newly diagnosed to help … Continued